147 related articles for article (PubMed ID: 37325926)
1. Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes.
Pulvirenti A; Hauser HF; Fiedler LM; McIntyre CA; Le T; Reidy-Lagunes DL; Soares KC; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Raj N; Wei AC
Ann Surg; 2024 Jan; 279(1):125-131. PubMed ID: 37325926
[TBL] [Abstract][Full Text] [Related]
2. The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine Tumors.
de Mestier L; Védie AL; Faron M; Cros J; Rebours V; Hentic O; Do Cao C; Bardet P; Lévy P; Sauvanet A; Ruszniewski P; Hammel P
Neuroendocrinology; 2020; 110(11-12):967-976. PubMed ID: 31791037
[TBL] [Abstract][Full Text] [Related]
3. Distinct clinicopathological and prognostic features of insulinoma with synchronous distant metastasis.
Gao H; Wang W; Xu H; Wu C; Jin W; Zhang S; Xu J; Ni Q; Yu X; Liu L
Pancreatology; 2019 Apr; 19(3):472-477. PubMed ID: 30850220
[TBL] [Abstract][Full Text] [Related]
4. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
[TBL] [Abstract][Full Text] [Related]
5. The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age.
Partelli S; Muffatti F; Rancoita PMV; Andreasi V; Balzano G; Crippa S; Doglioni C; Rubini C; Zamboni G; Falconi M
Dig Liver Dis; 2019 May; 51(5):735-740. PubMed ID: 30723019
[TBL] [Abstract][Full Text] [Related]
6. O-positive blood type is associated with prolonged recurrence-free survival following curative resection of pancreatic neuroendocrine tumors.
De Rycke O; Védie AL; Guarneri G; Nin F; De Flori C; Hentic O; Idri S; Sauvanet A; Rebours V; Cros J; Couvelard A; Ruszniewski P; de Mestier L
Pancreatology; 2020 Dec; 20(8):1718-1722. PubMed ID: 33032924
[TBL] [Abstract][Full Text] [Related]
7. Recurring Pancreatic Neuroendocrine Tumor: Timing and Pattern of Recurrence and Current Treatment.
Pulvirenti A; Javed AA; Michelakos T; Sekigami Y; Zheng J; Kalvin HL; McIntyre CA; Nebbia M; Chou JF; Gonen M; Raj N; Reidy-Lagunes DL; Zureikat AH; Ferrone CR; He J; Wei AC;
Ann Surg; 2023 Nov; 278(5):e1063-e1067. PubMed ID: 37796750
[TBL] [Abstract][Full Text] [Related]
8. Association between preoperative Vasostatin-1 and pathological features of aggressiveness in localized nonfunctioning pancreatic neuroendocrine tumors (NF-PanNET).
Andreasi V; Partelli S; Manzoni M; Muffatti F; Colombo B; Corti A; Falconi M
Pancreatology; 2019 Jan; 19(1):57-63. PubMed ID: 30470614
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.
Genç CG; Falconi M; Partelli S; Muffatti F; van Eeden S; Doglioni C; Klümpen HJ; van Eijck CHJ; Nieveen van Dijkum EJM
Ann Surg Oncol; 2018 Aug; 25(8):2467-2474. PubMed ID: 29789972
[TBL] [Abstract][Full Text] [Related]
10. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.
Wen J; Chen J; Liu D; Xu X; Fan M; Zhang Z
Neuroendocrinology; 2020; 110(5):364-376. PubMed ID: 31357196
[TBL] [Abstract][Full Text] [Related]
11. Is the Real Prevalence of Pancreatic Neuroendocrine Tumors Underestimated? A Retrospective Study on a Large Series of Pancreatic Specimens.
Partelli S; Giannone F; Schiavo Lena M; Muffatti F; Andreasi V; Crippa S; Tamburrino D; Zamboni G; Rubini C; Doglioni C; Falconi M
Neuroendocrinology; 2019; 109(2):165-170. PubMed ID: 31117106
[TBL] [Abstract][Full Text] [Related]
12. Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors.
Paiella S; Impellizzeri H; Zanolin E; Marchegiani G; Miotto M; Malpaga A; De Robertis R; D'Onofrio M; Rusev B; Capelli P; Cingarlini S; Butturini G; Davì MV; Amodio A; Bassi C; Scarpa A; Salvia R; Landoni L
World J Gastroenterol; 2017 May; 23(17):3092-3098. PubMed ID: 28533666
[TBL] [Abstract][Full Text] [Related]
13. Comparison of clinical features and pregnancy outcomes in early- and late-onset preeclampsia with HELLP syndrome: a 10-year retrospective study from a tertiary hospital and referral center in China.
Li B; Yang H
BMC Pregnancy Childbirth; 2022 Mar; 22(1):186. PubMed ID: 35260082
[TBL] [Abstract][Full Text] [Related]
14. Prediction of disease recurrence in patients after complete pancreatic NET (PanNET) G2 resection.
Olearska H; Sowa-Staszczak A; Morawiec-Sławek K; Kurzyńska A; Kolasa M; Tkacz E; Szumińska M; Hubalewska-Dydejczyk A; Opalinska M
Endokrynol Pol; 2024; 75(1):102-108. PubMed ID: 38497396
[TBL] [Abstract][Full Text] [Related]
15. Early-onset versus late-onset Crohn's disease: An Italian cohort study.
Cantoro L; Lenti MV; Monterubbianesi R; Cicala M; Giannarelli D; Papi C; Kohn A; Di Sabatino A
United European Gastroenterol J; 2020 Feb; 8(1):52-58. PubMed ID: 32213053
[TBL] [Abstract][Full Text] [Related]
16. Surgical Treatment of Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: An NCDB Analysis.
Kaslow SR; Vitiello GA; Prendergast K; Hani L; Cohen SM; Wolfgang C; Berman RS; Lee AY; Correa-Gallego C
Ann Surg Oncol; 2022 Jun; 29(6):3522-3531. PubMed ID: 35246811
[TBL] [Abstract][Full Text] [Related]
17. Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study.
Sadot E; Reidy-Lagunes DL; Tang LH; Do RK; Gonen M; D'Angelica MI; DeMatteo RP; Kingham TP; Groot Koerkamp B; Untch BR; Brennan MF; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2016 Apr; 23(4):1361-70. PubMed ID: 26597365
[TBL] [Abstract][Full Text] [Related]
18. Difference between early onset and late-onset pediatric ulcerative colitis.
Nambu R; Hagiwara S; Kubota M; Kagimoto S
Pediatr Int; 2016 Sep; 58(9):862-6. PubMed ID: 26833925
[TBL] [Abstract][Full Text] [Related]
19. A novel risk factor panel predicts early recurrence in resected pancreatic neuroendocrine tumors.
Wang WQ; Zhang WH; Gao HL; Huang D; Xu HX; Li S; Li TJ; Xu SS; Li H; Long J; Ye LY; Wu CT; Han X; Wang XH; Liu L; Yu XJ
J Gastroenterol; 2021 Apr; 56(4):395-405. PubMed ID: 33742253
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and postoperative survival in patients with sporadic versus multiple endocrine neoplasia type 1-related pancreatic neuroendocrine tumors: An international cohort study.
Bergquist JR; Shariq OA; Li AY; Worth PJ; Chatzizacharias N; Soonawalla Z; Athanasopoulos P; Toumpanakis C; Hansen P; Parks RW; Connor S; Parker K; Koea J; Srinivasa S; Ielpo B; Lopez EV; Norton JA; Lawrence B; Visser BC;
Surgery; 2022 Aug; 172(2):723-728. PubMed ID: 35577612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
